7-Chloro-3-(3-ethoxypropyl)-2-mercaptoquinazolin-4(3H)-one

Catalog No.: 
ACXHZF510
CAS No.: 
796067-61-3
Molecular Formula: 
C13H15ClN2O2S
Molecular Weight: 
298.80
7-Chloro-3-(3-ethoxypropyl)-2-mercaptoquinazolin-4(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00InquiryInquiry
100mg95%$100.00InquiryInquiry
250mg95%$132.00InquiryInquiry
1g95%$337.00InquiryInquiry
5g95%$944.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Chloro-3-(3-ethoxypropyl)-2-mercaptoquinazolin-4(3H)-one
IUPAC Name7-chloro-3-(3-ethoxypropyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one
MDL No.MFCD06370789
Molecular FormulaC13H15ClN2O2S
Molecular Weight298.80
SMILESO=C1N(CCCOCC)C(S)=NC2=C1C=CC(Cl)=C2
InChI KeyHTGUNJBJQKGJCC-UHFFFAOYSA-N
Synonym7-chloro-3-(3-ethoxypropyl)-2-sulfanylidene-1H-quinazolin-4-one;7-CHLORO-3-(3-ETHOXYPROPYL)-2-MERCAPTOQUINAZOLIN-4(3H)-ONE;4(1H)-Quinazolinone, 7-chloro-3-(3-ethoxypropyl)-2,3-dihydro-2-thioxo-;7-Chloro-3-(3-Ethoxypropyl)-2-Sulfanyl-3,4-Dihydroquinazolin-4-One
CAS No.796067-61-3

Synthetic Route by SureRoute

1. ACXHZF510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFHZJ532 route compound structure diagram
    ACFHZJ532111-35-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXHZF510 route product structure diagram
    ACXHZF510796067-61-3
Inquiry

2. ACXHZF510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXHZF510 route product structure diagram
    ACXHZF510796067-61-3
Inquiry

3. ACXHZF510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXHZF510 route product structure diagram
    ACXHZF510796067-61-3
Inquiry

Comments (0)